Mesa Laboratories (NASDAQ:MLAB) Issues Quarterly Earnings Results, Beats Expectations By $0.66 EPS

Mesa Laboratories (NASDAQ:MLAB) announced its earnings results on Tuesday. The medical instruments supplier reported $2.07 earnings per share for the quarter, beating the consensus estimate of $1.41 by $0.66, Zacks reports. Mesa Laboratories had a positive return on equity of 28.52% and a negative net margin of 107.56%.

Mesa Laboratories Stock Up 2.5 %

MLAB opened at $137.27 on Wednesday. Mesa Laboratories has a 1-year low of $83.68 and a 1-year high of $152.75. The business has a 50 day moving average price of $133.26 and a two-hundred day moving average price of $125.57. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.51 and a current ratio of 0.70.

Mesa Laboratories Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, March 17th. Investors of record on Friday, February 28th will be issued a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, February 28th. This represents a $0.64 annualized dividend and a yield of 0.47%. Mesa Laboratories’s payout ratio is -1.40%.

Wall Street Analyst Weigh In

Separately, StockNews.com cut shares of Mesa Laboratories from a “buy” rating to a “hold” rating in a research note on Wednesday, November 13th.

About Mesa Laboratories

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.